The inaugural episode of I See What You Did There was recorded at the New York Stock Exchange and features Bausch + Lomb Vision Care President Yang Yang and Vision Care R&D Vice President Bryan Reed. Fresh from an appearance at Bausch + Lomb Investor Day, they explain why there hasn't been a contact lens material breakthrough in over 25 years and share details on an exciting pipeline product that could end that streak and create an entirely new category of lenses. Come for the science, st...
All content for I See What You Did There is the property of Bausch + Lomb and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The inaugural episode of I See What You Did There was recorded at the New York Stock Exchange and features Bausch + Lomb Vision Care President Yang Yang and Vision Care R&D Vice President Bryan Reed. Fresh from an appearance at Bausch + Lomb Investor Day, they explain why there hasn't been a contact lens material breakthrough in over 25 years and share details on an exciting pipeline product that could end that streak and create an entirely new category of lenses. Come for the science, st...
The inaugural episode of I See What You Did There was recorded at the New York Stock Exchange and features Bausch + Lomb Vision Care President Yang Yang and Vision Care R&D Vice President Bryan Reed. Fresh from an appearance at Bausch + Lomb Investor Day, they explain why there hasn't been a contact lens material breakthrough in over 25 years and share details on an exciting pipeline product that could end that streak and create an entirely new category of lenses. Come for the science, st...
The inaugural episode of I See What You Did There was recorded at the New York Stock Exchange and features Bausch + Lomb Vision Care President Yang Yang and Vision Care R&D Vice President Bryan Reed. Fresh from an appearance at Bausch + Lomb Investor Day, they explain why there hasn't been a contact lens material breakthrough in over 25 years and share details on an exciting pipeline product that could end that streak and create an entirely new category of lenses. Come for the science, st...
